top of page

Oregon House Passes Bill To Allow Medical Marijuana Access For Patients In Hospice Care

  • Writer: Bob Marley
    Bob Marley
  • Feb 24
  • 3 min read

The Oregon House of Representatives has approved a bill that would allow patients with debilitating medical conditions to access medical marijuana in certain health facilities such as hospices.

The legislation from Rep. Farrah Chaichi (D) cleared the chamber in a 39-3 vote on Friday, sending it to the Senate for consideration. That chamber’s Health Care Committee is scheduled to take up the proposal on Wednesday.

HB 4142 would require hospice, palliative and home care organizations, as well as residential facilities, to develop rules permitting registered patients with debilitating conditions to use medical cannabis.

The reform is similar to—albeit somewhat more limited than—multiple “Ryan’s law” measures that have advanced in state legislatures across the country. Ryan’s law, which is named after a young cannabis patient in California who passed away, generally refers to a policy broadly permitting medical marijuana use in health facilities such as hospitals.

The Oregon bill wouldn’t extend to hospitals, but it would build upon the state’s medical cannabis program in a way that advocates say would meaningfully improve quality of life for seriously ill patients.

Under the proposal, the Oregon State Board of Nursing would further be prohibited “from disciplining a nurse who discusses the medical use of marijuana with a patient,” according to a legislative summary. It would additionally make it so eligible health facilities could act as medical marijuana caregivers if authorized by regulators.

The legislation “exempts residential facilities that provide a patient with medical marijuana from criminal laws related to the possession, delivery, or manufacture of marijuana” and “allows a conditionally designated residential facility to develop a written policy and train staff before the operative date,” the summary says.

If enacted into law, the measure would become operative on January 1, 2027.

“This bill is an important tool to facilitate cannabis use as an alternative or addition to opioid use in end-of-life care,” Chaichi said on the floor ahead of the vote. “While sometimes necessary, opioids are often overly sedative, preventing quality family time interactions in a person’s final days.”

“As someone who lost my mother while she was intubated, I know how meaningful it is for patients to be present and in the moment for their last days and weeks with their loved ones,” she said. “This is a quality of life and quality of care issue. The bill’s goal is to ensure patients who desire this important and valid medical treatment have access to it.”

Dena Swift, owner of Crossroads End of Life Doula Services, said in written testimony to the Senate committee ahead of its scheduled hearing that “cannabis has shown potential benefits in end-of-life care, particularly for individuals facing terminal illnesses.”

“It can help alleviate symptoms such as chronic pain, nausea, anxiety, and insomnia, which are common during this stage,” she said. “Additionally, cannabis may enhance the effectiveness of traditional medications, like opioids, by reducing the required dosage and minimizing side effects. This can contribute to improved comfort and quality of life for patients in their final days.”

—Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.

Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.—

Lawmakers in multiple states are advancing similar bills meant to provide patients with access to medical marijuana in health care facilities, with legislators across the U.S. making the case this week for a policy change they say is necessary to ensure patients have a full range of treatment options at their disposal.

Last week alone, Ryan’s law proposals saw action in at least four states: Colorado, Hawaii, Virginia and Washington State.

Photo courtesy of Chris Wallis // Side Pocket Images.

Comments


Global SEO Keywords

marihuana, cannabis, cáñamo, CBD, aceite de CBD, bálsamo de CBD, marijuana, hemp, weed, CBD oil, CBD balm, canapa, erba, olio di CBD, balsamo CBD, chanvre, herbe, huile de CBD, baume CBD, Marihuana, Cannabis, Hanf, Gras, CBD Öl, CBD Balsam, maconha, cânhamo, erva, óleo de CBD, bálsamo CBD, hennep, wiet, CBD olie, CBD balsem, hampa, gräs, CBD olja, CBD balsam, hamp, græs, gress, CBD olje, hamppu, ruoho, CBD öljy, CBD balsami, konopie, konopie indyjskie, olej CBD, balsam CBD, konopí, CBD olej, CBD balzám, konope, CBD balzam, marihuána, kannabisz, kender, fű, CBD olaj, CBD balzsam, canabis, cânepă, iarbă, ulei CBD, марихуана, канабис, коноп, CBD масло, CBD балсам, μαριχουάνα, κάνναβη, χασίς, λάδι CBD, βάλσαμο CBD, kanabis, konoplja, trava, CBD ulje, CBD olje, kanapės, kanapės indinės, CBD aliejus, CBD balzamas, marihuāna, kaņepes, CBD eļļa, CBD balzams, marihuaana, kanep, CBD õli, CBD palsam, kannabis, qanneb, żejt CBD, balsam CBD, marijúna, hampur, CBD olía, CBD smyrsl

Disclaimer

Jacob Hooy CBD Lip Balm is free from parabens and artificial colorants and contains no toxins or heavy metals, supporting natural body care. Our products are not intended to diagnose, treat, cure, or prevent any disease, medical condition, or symptom. The information provided on this website is for informational purposes only and must not be considered medical advice, nor a substitute for professional diagnosis, treatment, or guidance provided by qualified physicians, healthcare professionals, or pharmaceutical specialists. Nothing on this website should be interpreted as a recommendation, prescription, or therapeutic claim.

Difresh Spain is an online retail store registered under IAE Group 652.3, specializing in the retail trade of perfumery, cosmetic products, and personal hygiene and care items. NIF: Y3526859-F. E-mail: info@cbdvending.eu - WhatsApp: +34662918154 - Factory adress: Calle Albardín 13, Nave B07, 50720, La cartuja baja, Zaragoza, España. All prices include VAT and free shipping across all European Union countries.

© 2026 - www.cbdvending.euPrivacy Policy

bottom of page